Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -6.71x is 64% below its 1-year average of -4.10x, near the low end of its 1-year range (-6.71x–-2.18x).
As of the fiscal period ended Thursday, September 30, 2021. 59.09% below its 12-month average of -4.22x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2021 (2021-09-30): -6.71x.
INTEREST COVERAGE RATIO
-6.71x
INTEREST COVERAGE RATIO AVG TTM
-4.22x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-59.09%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-5.20%
vs the sector median at left
RenovoRx, Inc.
Market Cap
$62.62M
Interest Coverage Ratio
-6.71x
TTM Avg
-4.22x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$62.78M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$63.02M
Interest Coverage Ratio
0.34x
TTM Avg
0.34x
3Y Avg
1.90x
5Y Avg
3.13x
Market Cap
$63.78M
Interest Coverage Ratio
-58.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$64.18M
Interest Coverage Ratio
-66.90x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$60.42M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$60.02M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$65.85M
Interest Coverage Ratio
-632.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$65.86M
Interest Coverage Ratio
-21.57x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| RenovoRx, Inc. (RNXT) | $62.62M | -6.71x | -4.22x | N/A | N/A |
| Heron Therapeutics, Inc. (HRTX)vs › | $62.78M | N/A | N/A | N/A | N/A |
| InterCure Ltd. (INCR)vs › | $63.02M | 0.34x | 0.34x | 1.90x | 3.13x |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | -58.65x | N/A | N/A | N/A |
| Alps Group Inc (ALPS)vs › | $64.18M | -66.90x | N/A | N/A | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $60.42M | N/A | N/A | N/A | N/A |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.02M | N/A | N/A | N/A | N/A |
| XBiotech Inc. (XBIT)vs › | $65.85M | -632.78x | N/A | N/A | N/A |
| Cingulate Inc. (CING)vs › | $65.86M | -21.57x | N/A | N/A | N/A |
| Gossamer Bio, Inc. (GOSS)vs › | $65.87M | -14.86x | N/A | N/A | N/A |
Interest Coverage
-6.7x
Debt/Equity
0.03
Current Ratio
5.74
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-09-30 | -6.71x |
| 2021-06-30 | -2.18x |
| 2021-03-31 | -4.58x |
| 2020-12-31 | -2.72x |
| 2020-09-30 | -4.89x |
| 2020-06-30 | -3.52x |
